Published in Int Immunol on January 01, 2002
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. J Virol (2003) 1.70
Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge. Infect Immun (2007) 1.19
Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. J Virol (2006) 1.15
DNA vaccines: developing new strategies against cancer. J Biomed Biotechnol (2010) 1.12
Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology (2008) 1.07
Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol (2005) 1.02
Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol (2004) 1.00
A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus. J Infect Dis (2013) 0.95
Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis. PLoS One (2012) 0.94
The influence of delivery vectors on HIV vaccine efficacy. Front Microbiol (2014) 0.92
Prime-boost approaches to tuberculosis vaccine development. Expert Rev Vaccines (2012) 0.91
Gene Therapy Applications to Cancer Treatment. J Biomed Biotechnol (2003) 0.90
New approaches to design HIV-1 T-cell vaccines. Curr Opin HIV AIDS (2010) 0.88
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J Virol (2005) 0.88
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials. Viruses (2010) 0.86
Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides. J Virol (2009) 0.84
Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res (2012) 0.83
Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu. J Virol (2014) 0.81
CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals. Vaccine (2012) 0.80
Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa. Mucosal Immunol (2009) 0.80
Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein. BMC Microbiol (2005) 0.79
An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects. Oncoimmunology (2015) 0.78
Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS One (2009) 0.78
DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus. Hum Vaccin Immunother (2013) 0.78
Use of an in vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV-1 recombinant poxvirus vaccination. PLoS One (2014) 0.78
Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant. PLoS One (2016) 0.77
Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Vaccine (2016) 0.75
Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy. J Immunol (2017) 0.75
Immune Signature of Enhanced Functional Avidity CD8(+) T Cells in vivo Induced by Vaccinia Vectored Vaccine. Sci Rep (2017) 0.75
Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol (2003) 4.45
Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci U S A (2004) 3.61
Global human footprint on the linkage between biodiversity and ecosystem functioning in reef fishes. PLoS Biol (2011) 3.02
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet (2005) 2.28
Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A (2007) 1.91
Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun (2005) 1.65
Population structure, migration, and diversifying selection in the Netherlands. Eur J Hum Genet (2013) 1.47
Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series. BJU Int (2010) 1.46
Interleukin-17: an emerging role in lung inflammation. Am J Respir Cell Mol Biol (2003) 1.36
CD4+ T cell-independent DNA vaccination against opportunistic infections. J Clin Invest (2005) 1.33
Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol (2006) 1.31
Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care? Br J Gen Pract (2003) 1.26
Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol (2009) 1.18
Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. J Virol (2006) 1.15
Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J Immunol (2003) 1.15
Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. J Virol (2004) 1.14
Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies. J Immunol (2007) 1.07
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity. Expert Rev Vaccines (2009) 1.06
Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials. Vaccine (2005) 1.04
Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal. J Immunol (2002) 1.03
Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use. Vaccine (2005) 1.02
Induction and measurement of cytotoxic T lymphocyte activity. Curr Protoc Immunol (2006) 1.01
Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening. Arterioscler Thromb Vasc Biol (2005) 1.01
The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4. Antiviral Res (2005) 1.00
Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod (2003) 0.99
Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles. J Immunol (2007) 0.99
Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy. J Immunol (2008) 0.97
Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1. Vaccine (2006) 0.97
Subsoil erosion dominates the supply of fine sediment to rivers draining into Princess Charlotte Bay, Australia. J Environ Radioact (2013) 0.95
Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques. Vaccine (2005) 0.92
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine. Vaccine (2006) 0.92
Increased lead biomarker levels are associated with changes in hormonal response to stress in occupationally exposed male participants. Environ Health Perspect (2011) 0.91
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations. Vaccine (2011) 0.91
Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking. PLoS One (2012) 0.91
Prime-boost approaches to tuberculosis vaccine development. Expert Rev Vaccines (2012) 0.91
Replicability and heterogeneity of awake unrestrained canine FMRI responses. PLoS One (2013) 0.90
Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12. Vaccine (2004) 0.90
Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression. Neurochem Res (2004) 0.89
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity. Eur J Immunol (2009) 0.89
Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine. J Virol (2002) 0.89
Prime-boost strategies in DNA vaccines. Methods Mol Med (2006) 0.86
Association of substance dependence phenotypes in the COGA sample. Addict Biol (2014) 0.85
Cis-regulatory variants affect CHRNA5 mRNA expression in populations of African and European ancestry. PLoS One (2013) 0.85
Alteration of peripheral blood monocyte gene expression in humans following diesel exhaust inhalation. Inhal Toxicol (2012) 0.84
Human immunodeficiency virus-1 vaccine design: where do we go now? Immunol Cell Biol (2010) 0.84
Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine. J Virol (2010) 0.83
Sarcomatoid carcinoma involving the renal pelvis and ureter with heterologous osteosarcomatous differentiation. Pathology (2012) 0.83
Association between autozygosity and major depression: stratification due to religious assortment. Behav Genet (2013) 0.83
Evaluating vaccinia virus cytokine co-expression in TLR GKO mice. Immunol Cell Biol (2010) 0.83
Assessing blood pressure control in patients treated for hypertension: comparing different measurements and targets. Br J Gen Pract (2006) 0.82
Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines: implications for future trials. Hum Vaccin (2006) 0.82
The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. Cell Microbiol (2006) 0.82
Reproductive aging is associated with altered gene expression in human luteinized granulosa cells. Reprod Sci (2009) 0.81
CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals. Vaccine (2012) 0.80
Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cells. Microbes Infect (2003) 0.79
Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection. Vaccine (2010) 0.79
Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis. Vaccine (2011) 0.78
Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes. J Virol Methods (2011) 0.78
Effects of unfocused extracorporeal shock wave therapy on healing of wounds of the distal portion of the forelimb in horses. Am J Vet Res (2010) 0.78
Porcine cells express more than one functional ligand for the human lymphocyte activating receptor NKG2D. Xenotransplantation (2009) 0.78
In vivo assessment of effect of fermented milk diet on course of infection in mice with bioluminescent Salmonella. J Food Prot (2003) 0.77
Exploiting 4-1BB costimulation for enhancing antiviral vaccination. Viral Immunol (2006) 0.76
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells. J Neuroimmunol (2012) 0.76
Cytokines, skin, and smallpox-a new link to an antimicrobial Peptide. Immunity (2006) 0.75
Corrigendum. CD4+ T cell-independent DNA vaccination against opportunistic infections. J Clin Invest (2015) 0.75
Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques. AIDS Res Hum Retroviruses (2005) 0.75
Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissue. Immunol Cell Biol (2005) 0.75
Information systems for biobanks/biorepositories: handling information associated with compliant sample management. Biopreserv Biobank (2010) 0.75